Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: Results from an in vitro and a dietary supplement study

American Journal of Clinical Nutrition

Volumn 67, Issue 2, 1998, Pages 255-262

  Janssen, P L T M Karin ^b   Mensink, Ronald P ^b   Cox, Frank J J ^b   Harryvan, Jan L ^b   Hovenier, Robert ^b   Hollman, Peter C H ^b   Katan, Martijn B ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b NONE

Author keywords

Apigenin; Diet; Factor VII; Fibrinogen; Flavonoid; Hemostasis; Humans; In vitro study; Onions; PAI 1; Parsley; Plasminogen; Plasminogen activator inhibitor 1; Platelet aggregation; Quercetin; Thromboxane

Indexed keywords

APIGENIN; BLOOD CLOTTING FACTOR 7; CATECHIN; ISOQUERCITRIN; QUERCETIN; THROMBOXANE B2;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; FEMALE; FOOD INTAKE; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ONION; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION;

ALLIUM CEPA; PETROSELINUM CRISPUM;

EID: 0031908477     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/67.2.255     Document Type: Article

References (45)

1. Kühnau J. The flavonoids: a class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 1976;24:117-91.
2. Markham KR. Flavones, flavonols and their glycosides. Methods Plant Biochem 1989;l:197-235.
3. Herrmann K. On the occurrence of flavonol and flavone glycosides in vegetables. Z Lebensm Unters Forsch 1988;186:1-5.
4. Herrmann K. Flavonols and flavones in food plants: a review. J Food Technol 1976;11:433-48.
5. Hertog MGL, Hollman PCH, Katan MB, Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer 1993;20:21-9.
6. Keli SO, Hertog MGL, Feskens EJM, Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke. Arch Intern Med 1996;156:637-42.
7. Knekt P, Reunanen RJ, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. Br Med J 1996;312:478-81.
8. Hertog MGL, Kromhout D, Aravanis C, et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries. Arch Intern Med 1995;155:381-6.
9. Hertog MGL, Feskens EJ, Hollman PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993;342:1007-11.
10. Rimm ER, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Arch Intern Med 1996;125:384-9.
11. Hertog MGL, Sweetnam PM, Fehily AM, Elwood PC, Kromhout D. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr 1997;65:1489-94.
12. Hollman PCH, Hertog MGL, Katan MB. Role of dietary flavonoids in protection against cancer and coronary heart disease. Biochem Soc Trans 1996;24:785-9.
13. Hertog MGL, Hollman PCH. Potential health effects of the dietary flavonol quercetin. Eur J Clin Nutr 1996;50:63-71.
14. Landolfi R, Mower RL, Steiner M. Modification of platelet function and arachidonic acid metabolism by bioflavonoids: structure-activity relations. Biochem Pharmacol 1984;33:1525-30.
15. Laughton MJ, Evans PJ, Moroney MA, Hoult JR, Halliwell B. Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives: relationship to antioxidant activity and to iron ion-reducing ability. Biochem Pharmacol 1991;42:1673-81.
16. Mower RL, Landolfi R, Steiner M. Inhibition of in vitro platelet aggregation and arachidonic acid metabolism by flavones. Biochem Pharmacol 1984;33:357-63.
17. Gryglewski RJ, Korbut R, Robak J, Swies J. On the mechanism of antithrombotic action of flavonoids. Biochem Pharmacol 1987;36:317-22.
18. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM, The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 1995;235:207-19.
19. Beretz A, Briancon Scheid F, Stierle A, Corre G, Anton R, Cazenave JP. Inhibition of human platelet cyclic AMP phosphodiesterase and of platelet aggregation by a hemisynthetic flavonoid, amentoflavone hexaacetate. Biochem Pharmacol 1986;35:257-62.
20. Corvazier E, Maclouf J. Interference of some flavonoids and nonsteroidal anti-inflammatory drugs with oxidative metabolism of arachidonic acid by human platelets and neutrophils. Biochim Biophys Acta 1985;835:315-21.
21. Moroney MA, Alcaraz MJ, Forder RA, Carey F, Hoult JR. Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids. J Pharm Pharmacol 1988;40:787-92.
22. Hollman PCH, de Vries JHM, van Leeuwen SD, Mengelers MJB, Katan MB. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 1996;62:1276-82.
23. Hollman PCH, van der Gaag MS, Mengelers MJB, de Vries JHM, Katan MB. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic Biol Med 1996;21:703-7.
24. Beretz A, Cazenave JP. The effect of flavonoids on blood-vessel wall interactions. In: Cody V, Middleton E, Harborne JB, Beretz A, eds. Plant flavonoids in biology and medicine. II: Biochemical, cellular, and medicinal properties. New York: Alan R Liss, 1988:187-200.
25. Middleton EJ, Kandaswami C. Effects of flavonoids on immune and inflammatory cell functions. Biochem Pharmacol 1992;43:1167-79.
26. Beretz A, Cazenave JP. Old and new natural products as the source of modern antithrombotic drugs. Planta Med 1991;57:S68-72.
27. Badimon JJ, Fuster V, Chesebro JH, Badimon L. Coronary atherosclerosis: a multifactorial disease. Circulation 1993;87(suppl):II-3-16.
28. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 1993;362:801-9.
29. Meade TW, Cooper JA, Chakrabarti R, Miller GJ, Stirling Y, Howarth DJ. Fibrinolytic activity and clotting factors in ischemic heart disease in women. Br Med J 1996;312:1581.
30. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischemic heart disease in the Northwick Park Heart Study. Lancet 1993;342:1076-9.
31. Hamsten A, de Faire U, Walldius G, et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987;2:3-9.
32. Munkvad S, Gram J, Jespersen J. A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction. Eur Heart J 1990; 11:525-8.
33. Haslam E. Plant polyphenols: vegetable tannins revisited. Cambridge, United Kingdom: Cambridge University Press, 1989.
34. Baumann J, von Bruchhausen F, Wurm G. Flavonoids and related compounds as inhibition of arachidonic acid peroxidation. Prostaglandins 1980;20:627-39.
35. Hertog MGL, Hollman PCH, Venema DP. Optimization of a quantitative HPLC determination of potentially anticarcinogenic flavonoids in vegetables and fruits. J Agric Food Chem 1992;40:1591-8.
36. Hertog MGL, Hollman PCH, van de Putte B. Flavonol and flavone content of beverages. J Agric Food Chem 1993;41:1242-6.
37. Hertog MGL, Hollman PCH, Katan MB. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Agric Food Chem 1992;40:2379-83.
38. Blacquiere C, van de Pol L. Kruiden en specerijen: het voorkomen van carcinogenen en anticarcinogenen, de consumptie, het flavonoidgehalte. (Herbs and spices: the presence of carcinogens and anticarcinogens, consumption, flavonoid content.) Wageningen. Netherlands: Department of Human Nutrition, 1993.
39. Cameron ME, van Staveren WA. Manual on methodology for food consumption studies. Oxford, United Kingdom: Oxford University Press, 1988:83-8.
40. 2 production. Eur J Clin Nutr 1995;49:365-70.
41. Hollman PCH, Van Trijp JMP, Buysman MNCP. Fluorescence detection of flavonoids in HPLC by postcolumn chelation with aluminum. Anal Chem 1996;68:3511-5.
42. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. 2nd ed. Belmont, CA: Duxbury Press, 1988.
43. SAS Institute Inc. SAS/STAT user's guide 6. Gary, NC: SAS Institute Inc, 1989.
44. Maderna P, Caruso D, Tremoli E, Galli G. Differential effects of oral administrations to human volunteers of acetylsalicylic acid, sodium salicylate and indomethacin on 12-hydroxyeicosatetraenoic acid formation by stimulated platelets. Thromb Res 1988; 52:197-206.
45. Srivastava KC. Effect of onion and ginger consumption on platelet thromboxane production in humans. Prostaglandins Leukot Essent Fatty Acids 1989;35:183-5.